Investment strategy

We invest in next-generation life science companies based on intellectual property created within our own research community.  We seek strong co-investor syndicates to develop products across a range of categories including drugs, devices, diagnostics and digital health.​

Initial investments are directed at the seed and Series A stages, where our participation attracts capital and talent into the most difficult-to-fund phase of company development. When we invest, we expect to support each portfolio company through its entire financing lifecycles.

In addition to providing the necessary venture capital, we leverage our experience in starting and growing companies, our expertise in the medical industry, and our network of scientific and business talent to build great companies.


Proprietary resources

  • Novel Biological Insights


  • Pre-clinical, clinical, post-approval, and observational research​

  • Longitudinal patient data:  intervention, cost, outcomes, patient behavior, and population management

  • Tissue and other biorepositories

  • Big Data and connected health



  • Clinicians And Scientists Working Together 

  • Clinicians collaborating on-site with investigators and scientists


  • Identifying unmet medical needs


  • Harnessing unparalleled medical talent and scientific resources


  • Creating solutions to improve the lives and outcomes of patients




Our unique company creation model benefits from early access to breakthrough innovations from the largest academic research entity in the United States with an unmatched concentration of scientific talent and clinical resources.